Malathion Poisoning: Symptoms, Treatment, and Prevention

Malathion poisoning occurs when the widely used organophosphate pesticide overwhelms the body’s ability to break it down, triggering a cascade of effects centered on uncontrolled nerve stimulation. Acute poisoning can progress from excessive sweating and salivation to muscle paralysis and respiratory failure within hours, and without prompt treatment it can be fatal. The condition is most common after accidental ingestion or heavy occupational exposure, though the severity depends on the dose, the route of exposure, and individual differences in how quickly a person’s body detoxifies the chemical.

How Malathion Becomes Dangerous in the Body

Malathion itself is not the primary toxin. Once it enters the body, liver enzymes convert a fraction of it into malaoxon, a far more potent compound that blocks an enzyme called acetylcholinesterase. That enzyme normally clears acetylcholine, a chemical messenger, from nerve junctions after it has done its job. When malaoxon shuts the enzyme down, acetylcholine piles up at nerve endings throughout the body, and nerves keep firing without an off switch.¹

What makes malathion less immediately lethal than many other organophosphates is that another group of enzymes, carboxylesterases, can break it down before malaoxon ever forms. In most people, this detox pathway works fast enough that casual contact with diluted malathion causes no symptoms at all. Trouble starts when the dose is large enough, or the route direct enough, to overwhelm these protective enzymes. Swallowing a concentrated solution is the classic scenario for severe poisoning; skin and lung absorption from agricultural spraying can also reach toxic levels without protective gear.

Recognizing the Symptoms

The early signs of malathion poisoning reflect the flood of acetylcholine hitting receptors in glands, smooth muscle, and the nervous system. Clinicians sometimes use the mnemonic DUMBELS to remember the cluster: diarrhea, urination, miosis (constricted pupils), bronchospasm (tight airways with wheezing), emesis (vomiting), lacrimation (tearing), and salivation. These muscarinic effects often appear within minutes to a few hours of a significant exposure.²

At the same time, acetylcholine overstimulates the neuromuscular junctions that control voluntary muscles. Fasciculations, the visible twitching of muscles under the skin, are a hallmark. In severe cases these progress to muscle weakness and then paralysis. Convulsions can occur and tend to be clonic in character, meaning rapid repetitive jerking rather than sustained rigidity.²

Central nervous system effects add another layer. Agitation, confusion, and loss of consciousness may develop. The most dangerous endpoint is respiratory failure: a combination of bronchospasm clamping down the airways, excessive secretions flooding the lungs, and paralysis of the diaphragm and chest-wall muscles. Without intervention, this sequence leads to asphyxiation.

How Poisoning Is Confirmed

In a clear-cut case where someone is known to have swallowed malathion and arrives with the classic symptom cluster, diagnosis is largely clinical. But exposure is not always obvious, especially with skin contact that the person may not recall or report. Blood tests for cholinesterase levels can confirm suspicion. Serum cholinesterase drops quickly once the person is symptomatic, and red blood cell cholinesterase provides a more stable marker of exposure. In one reported case of poisoning through skin application of a concentrated malathion pesticide, both values on admission were well below half of the normal reference range.³

A practical point for emergency physicians: if cholinesterase levels come back normal, systemic organophosphate poisoning is effectively ruled out. The catch is that the lab results often take time to return, sometimes days, so treatment decisions in the emergency department are based on the clinical picture, not on waiting for blood work.

Emergency Treatment

The immediate priorities are straightforward: stabilize breathing, reduce the acetylcholine overload, and reactivate the blocked enzyme if possible.

Atropine: This drug directly blocks acetylcholine at muscarinic receptors, drying up secretions and opening the airways. Doses in organophosphate poisoning are often far higher than those used for other conditions, and the drug is typically given as repeated boluses or a continuous infusion. In a published case of severe malathion poisoning, intravenous atropine infusion was needed for 13 days before secretions stopped, and the patient suffered cardiac arrests on days when the infusion rate dipped too low.⁴
Pralidoxime: An oxime drug that can reactivate acetylcholinesterase if given early enough, before the bond between the enzyme and the organophosphate “ages” and becomes permanent. It is usually started alongside atropine.
Airway management: Many severe cases require intubation and mechanical ventilation. The same case noted above involved intubation in the emergency department and administration of activated charcoal through a nasogastric tube to limit further absorption from the gut.⁴

Decontamination matters too. Removing clothing and washing the skin with soap and water prevents ongoing absorption through the skin. If ingestion occurred recently, gastric lavage (stomach pumping) may be considered, though its benefit over simply giving activated charcoal remains debated, and clinical trials have struggled to settle the question definitively.⁵

Complications That Follow the Acute Crisis

Surviving the initial cholinergic storm is not the end of the story. Organophosphate poisoning can trigger at least two delayed neurological syndromes, and both can appear after the acute symptoms have resolved, catching patients and clinicians off guard.

Intermediate Syndrome

Roughly one in five patients who swallow an organophosphate pesticide develops intermediate syndrome, typically two to four days after exposure, just as the acute muscarinic symptoms are fading. The hallmark is progressive weakness of the respiratory muscles, including the diaphragm and the muscles between the ribs, along with weakness in the neck and upper limbs.⁶ Facial muscle weakness and drooping eyelids are common accompanying signs.⁷

The danger is respiratory failure. A case report of a seven-year-old boy who ingested malathion illustrates the pattern: his acute cholinergic crisis lasted four days, then gave way to respiratory distress, trouble swallowing, and low oxygen levels. He required mechanical ventilation for 21 days.⁸ The severity varies; some patients develop only mild neck weakness, while others progress to near-complete paralysis of the breathing muscles and need prolonged ventilatory support.⁶ In settings with limited access to intensive care, this complication can be fatal.⁹

Delayed Polyneuropathy

A second complication, organophosphate-induced delayed polyneuropathy, can emerge one to four weeks after exposure. It involves degeneration of nerve fibers in both the limbs and the spinal cord. Early symptoms include cramping pain in the legs, numbness, and tingling, followed by progressive weakness. The characteristic sign is bilateral foot drop, a high-stepping walk caused by the inability to lift the front of the feet. In severe cases, the hands are affected too, and patients may develop wrist drop and even quadriplegia.¹⁰

This complication is driven by a different molecular target than the acute poisoning. Rather than acetylcholinesterase, the culprit is damage to an enzyme called neuropathy target esterase. Recovery from delayed polyneuropathy is slow and often incomplete, making prevention of severe exposure all the more important.

Beyond Acute Poisoning: Organ Damage and Chronic Effects

Research in animal models has been building a picture of malathion toxicity that goes beyond the classic cholinergic story. The liver and kidneys appear to be the primary target organs for chronic damage. Malathion triggers oxidative stress, a state where destructive reactive molecules overwhelm the cell’s defenses. In rodent studies, markers of oxidative damage in the liver and kidneys rise sharply, while protective antioxidant molecules like glutathione drop by roughly a fifth to a half of normal levels depending on the dose.¹¹

The brain is also vulnerable. Animal data point to mitochondrial dysfunction and oxidative damage as contributors to neurobehavioral problems after malathion exposure, effects that operate alongside and independently of the cholinergic toxicity.¹¹ Male reproductive toxicity has also been observed in these models, with testicular oxidative stress and decreased testosterone levels. These findings come from laboratory animals, so translating exact dose-response curves to humans is difficult, but they underscore that malathion is not harmless simply because acute cholinergic symptoms have been avoided. At the cellular level, malathion exposure reduces antioxidant enzyme activity and ATP production while ramping up the production of reactive oxygen species, driving damage to cell membranes and triggering cell death in liver and kidney tissue.¹²

How Exposure Typically Happens

Malathion is one of the most widely used insecticides worldwide, applied in agriculture, public health mosquito control programs, and even in medicated shampoos for head lice. The routes of human exposure vary accordingly.

For agricultural workers, dermal absorption is the biggest exposure pathway. Studies monitoring greenhouse applicators found that even at low spraying pressures, a measurable volume of spray solution contacts the worker’s skin, and the amount increases substantially at higher pressures. Hands and forearms catch the heaviest dose, and the type of gloves worn makes a real difference: cotton gloves absorb more pesticide than rubber ones, which repel it.¹³ Inhalation exposure during spraying is typically lower than skin contact but still measurable, as monitored through personal air samplers worn by applicators.¹⁴

Accidental ingestion by children, self-harm by ingestion, and inappropriate use of concentrated agricultural formulations on the skin (mistaking them for head-lice products) round out the major exposure scenarios. The case of dermal poisoning cited earlier in this article involved a patient who applied a concentrated malathion pesticide to the skin, apparently confusing it with a pharmaceutical preparation.³

Prevention for Workers and Households

Reducing malathion poisoning is overwhelmingly a matter of controlling exposure. For agricultural and pest-control workers, personal protective equipment is the single most impactful variable. A study of pesticide applicators found that not wearing gloves while mixing pesticides and not wearing a mask while spraying were the major factors associated with elevated organophosphate metabolite levels in urine. The differences were not subtle: workers who skipped gloves or masks had significantly higher internal exposure than those who wore them.¹⁵

Practical prevention measures include:

Chemical-resistant gloves: Rubber or nitrile gloves during mixing and application; cotton gloves absorb rather than repel the pesticide.
Respiratory protection: A properly fitted mask or respirator during spraying, especially in enclosed spaces like greenhouses.
Coveralls and eye protection: Minimizing skin contact across the whole body matters, since spray drift can settle on arms, torso, and face.
Post-work hygiene: Showering and changing clothes immediately after application prevents ongoing dermal absorption.
Secure storage: Keeping concentrated malathion in clearly labeled, locked containers prevents accidental ingestion by children and confusion with household products.

For household use, pharmaceutical-grade malathion shampoos for head lice are formulated at far lower concentrations than agricultural products. A study of malathion shampoo used in schoolchildren found that side effects were mild, including nausea in about 4% of students and a burning sensation in about 7%. Although red blood cell cholinesterase activity showed a statistically detectable dip after two applications, all values remained within the normal range, and no clinical signs of toxicity were observed.¹⁶ The message is that the pharmaceutical formulation is not comparable in risk to concentrated agricultural malathion, but the two should never be confused or substituted for one another.

Why Some People Are More Vulnerable

Not everyone metabolizes organophosphates at the same rate. A key enzyme called paraoxonase-1, or PON1, helps break down organophosphates in the bloodstream. Two well-studied genetic variations in the gene for this enzyme affect how efficiently it works, and the distribution of these variants differs across populations. People who carry less active versions of PON1 metabolize certain organophosphates more slowly, and studies have shown that individuals with specific genotypes develop symptoms of toxicity at higher rates than others.¹⁷

Children are also at heightened risk for several reasons that have nothing to do with genetics. Their lower body weight means a given quantity of malathion translates to a higher dose per kilogram. Their skin-to-body-mass ratio is larger, so proportionally more pesticide can be absorbed dermally. And young children are more likely to encounter malathion through hand-to-mouth behavior in areas where the chemical has been applied. The case of the seven-year-old who developed both intermediate syndrome and required weeks of ventilation is a reminder that pediatric malathion poisoning can be severe and prolonged.

Malathion in Public Health Mosquito Control

Malathion is still sprayed aerially and from trucks in many parts of the world to control mosquito populations, particularly during outbreaks of mosquito-borne diseases. This use raises a different question from occupational or accidental poisoning: does community-wide spraying at approved concentrations pose a health risk to residents?

A scoping review of the available evidence found no clear association between organophosphates used for adult mosquito control, applied according to EPA label instructions, and adverse human health effects.¹⁸ An earlier large-scale natural experiment reinforced this: when malathion was aerially sprayed across roughly 13,000 square miles of the San Francisco Bay area, researchers examining newborn hospital records found no biologically plausible pattern of association between exposure and birth defects or low birthweight.¹⁹

The distinction is dose. Public health spraying uses concentrations orders of magnitude lower than the amounts that cause acute poisoning, and the droplets are designed to target flying insects rather than to saturate surfaces. This does not mean community concern is irrational; the evidence base for long-term low-level exposure remains thinner than anyone would like, and the scoping review itself noted that better guidance for assessing health effects after community spraying is needed. But the available data suggest the risk from properly applied mosquito control spraying is very different from the risk of handling concentrated agricultural malathion without protection.

Effects on Pollinators and the Wider Environment

Malathion is not selective about which insects it kills. Its impact on honey bees has drawn increasing attention, especially because the conversion to malaoxon happens in the environment too, not just in human livers. Research examining residues in pollen from treated rapeseed found substantial initial deposits of both malathion and malaoxon. The two mirror-image forms of malathion (its R- and S-enantiomers) turned out to be strikingly different in toxicity to bees: the R-form was roughly five times more lethal by mouth than the S-form. The R-form also degraded more slowly in pollen, compounding the risk.²⁰

This finding matters beyond entomology. Crop pollination depends on bee health, and the recognition that standard risk assessments may underestimate malathion’s danger to pollinators by treating its two mirror forms as equivalent has implications for how regulators evaluate the pesticide. For home gardeners and small-scale growers, the practical takeaway is to avoid spraying malathion on or near flowering plants during the hours when bees are foraging.

1
PubMed. Malathion bioactivation in the human liver: the contribution of different cytochrome p450 isoforms
2
Forensic Science International. Case study: fatal poisoning by malathion
3
Proceedings of Singapore Healthcare / ResearchGate. Organophosphate poisoning from inappropriate topical use of malathion pesticide: A case report
4
Prehospital and Disaster Medicine. Challenges in the Management of Malathion Poisoning
5
BioMed Central / PubMed Central. Gastric lavage in acute organophosphorus pesticide poisoning (GLAOP)–a randomised controlled trial of multiple vs. single gastric lavage in unselected acute organophosphorus pesticide poisoning
6
PubMed. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy
7
PLoS Medicine. The Spectrum of Intermediate Syndrome Following Acute Organophosphate Poisoning: A Prospective Cohort Study from Sri Lanka
8
Academia.edu (Journal of Pediatric Intensive Care). Cholinergic crisis, intermediate syndrome and delayed polyneuropathy following malathion poisoning
9
PubMed Central. Intermediate syndrome following organophosphate poisoning: A case report in a low resource and poor socio-economic setting
10
PubMed. Organophosphate-induced delayed polyneuropathy
11
PubMed. Tissue-specific oxidative stress and protective interventions in malathion-induced toxicity in rodent models: A comprehensive review
12
PubMed Central. MitoQ alleviates malathion‑induced hepatorenal toxicity via oxidative stress and inflammation modulation
13
PubMed. Determination of potential dermal and inhalation operator exposure to malathion in greenhouses with the whole body dosimetry method
14
PubMed. Gas chromatographic-tandem mass spectrometric analytical method for the study of inhalation, potential dermal and actual exposure of agricultural workers to the pesticide malathion
15
PubMed Central. Exposure to organophosphate insecticides, inappropriate personal protective equipment use, and cognitive performance among pesticide applicators
16
PubMed. Clinical response and safety of malathion shampoo for treatment of head lice in a primary school
17
Toxicology. Paraoxonase-1 Genetic Polymorphisms in Organophosphate Metabolism
18
PubMed Central. A scoping review to determine if adverse human health effects are associated with use of organophosphates for mosquito control
19
PubMed Central. Exposure to aerial malathion application and the occurrence of congenital anomalies and low birthweight
20
Science of The Total Environment. Ecological threat caused by malathion and its chiral metabolite in a honey bee-rape system: Stereoselective exposure risk and the mechanism revealed by proteome